Recently, Cannito et al. (110) have suggested that SerpinB3, a serine protease inhibitor, can stimulate proliferation of hepatic tumor cells and subsequently facilitate HCC progression by enhancing the stabilization of HIF2α by promoting the direct and selective neddylation of HIF2α (111). This evidence concerns the gene EPAS1 and hepatocellular carcinoma.